Head to Head Analysis: Envoy Medical (NASDAQ:COCH) & LogicMark (NASDAQ:LGMK)

Envoy Medical (NASDAQ:COCH) and LogicMark (NASDAQ:LGMK) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership.

Profitability

This table compares Envoy Medical and LogicMark’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-4,564.57%	N/A	-125.15%
LogicMark	-146.14%	-104.48%	-79.87%

Insider & Institutional Ownership

8.6% of Envoy Medical shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 60.5% of Envoy Medical shares are owned by insiders. Comparatively, 3.5% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings and Valuation

This table compares Envoy Medical and LogicMark”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$320,000.00	129.24	-$29.91 million	N/A	N/A
LogicMark	$9.74 million	0.11	-$14.55 million	($9.84)	-0.02

LogicMark has higher revenue and earnings than Envoy Medical.

Analyst Recommendations

This is a summary of current ratings and target prices for Envoy Medical and LogicMark, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	4	0	3.00
LogicMark	0	0	0	0	0.00

Envoy Medical currently has a consensus target price of $7.92, indicating a potential upside of 275.20%. Given Envoy Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than LogicMark.

Risk and Volatility

Envoy Medical has a beta of 2.38, suggesting that its stock price is 138% more volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.25, suggesting that its stock price is 25% more volatile than the S&P 500.

Summary

Envoy Medical beats LogicMark on 8 of the 12 factors compared between the two stocks.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.